NCT07799610 Senior Center Medication Safety and Empowerment Curriculum
| NCT ID | NCT07799610 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | Older Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2026-02-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Team Alice's Medication Safety and Empowerment Curriculum (MedSEC) helps older adults and caregivers learn how to safely manage medications. Many seniors take multiple medications, which can lead to harmful side effects or unnecessary treatments. This program, developed at the University at Buffalo, will be offered at senior centers in Western New York. It includes two interactive sessions that teach participants how to recognize medication risks and talk with their doctors about safer options. The curriculum uses videos, group discussions, and hands-on tools to build confidence and knowledge. It follows the "4Ms" of Age-Friendly Health Systems: What Matters, Medication, Mentation, and Mobility. A "Train-the-Trainer" model will help senior center staff continue the program long-term. The goal is to reduce medication harm, improve communication with healthcare providers, and support healthy aging in the community.
Eligibility Criteria
Inclusion Criteria: * 55 years of age and above * taking prescription medications Carepartner Inclusion Criteria: * currently an informal or formal care partner for an eligible patient (regardless of whether they live with or near the patient) * aged 18 years of age and above Exclusion Criteria: * Patients with cognitive impairment that prevents their self-management of medications.
Frequently Asked Questions
Who can join the NCT07799610 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07799610 currently recruiting?
Yes, NCT07799610 is actively recruiting participants. Visit ClinicalTrials.gov or contact State University of New York at Buffalo to inquire about joining.
Where is the NCT07799610 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07799610 clinical trial?
NCT07799610 is sponsored by State University of New York at Buffalo. The trial plans to enroll 125 participants.